New York, NY USA

Our News on Newswise

Memorial Sloan Kettering Study Shows New Kind of Targeted Drug Has Promise for Leukemia Patients

A new type of cancer therapy that targets an oncometabolite produced dramatic results in patients with advanced leukemia in an early-phase clinical trial.
7-Dec-2014 12:30 PM EST

Studies Led by Memorial Sloan Kettering Investigators Show Immunotherapy Drugs Improve Outcomes in Hodgkin Lymphoma Patients

In recent years, a number of scientific breakthroughs have led to the development of drugs that unleash the power of the immune system to recognize and attack cancer. For Classical Hodgkin lymphoma patients, two phase I studies are already...
6-Dec-2014 1:00 PM EST

Positive Data from Pivotal Phase III Study Could Improve Standard of Care for Hodgkin Lymphoma Patients

In a late-stage clinical trial, Hodgkin lymphoma patients who received brentuximab vedotin post-transplant lived longer without disease progression than patients who received only supportive care.
6-Dec-2014 11:00 AM EST

Memorial Sloan Kettering Team Makes Key Discovery in Understanding Immunotherapy’s Successes—and Its Failures

A collaborative team of leaders in the field of cancer immunology from Memorial Sloan Kettering Cancer Center has made a key discovery that advances the understanding of why some patients respond to ipilimumab, an immunotherapy drug, while others do...
19-Nov-2014 5:00 PM EST

Memorial Sloan Kettering Brings Cancer Care Closer to Home for Hudson Valley Residents

Memorial Sloan Kettering’s suburban presence is expanding with its newest and largest state-of-the-art facility set to welcome patients on October 6 in West Harrison, New York.
1-Oct-2014 9:50 AM EDT

New Academic-Industry Partnership Creates Online Registry for Patients Tested for Inherited Cancer Risk

The registry will provide data vital to improving understanding of newly discovered, cancer-associated genes and allow current and future generations to better interpret and benefit from knowledge of their genomes.
23-Sep-2014 5:00 PM EDT

The Newest Precision Medicine Tool: Prostate Cancer Organoids

Research led by investigators at Memorial Sloan Kettering Cancer Center has shown for the first time that organoids derived from human prostate cancer tumors can be grown in the laboratory, giving researchers an exciting new tool to test cancer...
29-Aug-2014 11:00 AM EDT

Medical Director Appointed at Memorial Sloan Kettering’s Locations in Westchester, New Jersey, and Long Island

Ephraim Casper, MD, has been appointed Medical Director for the Memorial Sloan Kettering Regional Care Network, comprised of six outpatient suburban locations — three on Long Island; two in Westchester County, New York; and one in Basking Ridge,...
31-Jul-2014 2:00 PM EDT

Our YouTube Videos